These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7058911)

  • 1. Acute interaction of vasopressin and neurogenic mechanisms in DOC-salt hypertension.
    Matsuguchi H; Schmid PG
    Am J Physiol; 1982 Jan; 242(1):H37-43. PubMed ID: 7058911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central mechanisms in DOC-salt hypertensive rats.
    Matsuguchi H; Sharabi FM; O'Connor G; Mark AL; Schmid PG
    Clin Exp Hypertens A; 1982; 4(8):1303-21. PubMed ID: 7116668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contributions of vasopressin and other pressor systems to DOC-salt hypertension in rats.
    Mento PF; Wang HH; Sawyer WH
    Proc Soc Exp Biol Med; 1984 Jan; 175(1):58-63. PubMed ID: 6694969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pressor response to vasopressin and norepinephrine in DOC-salt hypertensive and prehypertensive rats.
    Ouchi Y; Yazaki Y; Tsai RC; Ashida T
    Tohoku J Exp Med; 1988 Feb; 154(2):125-33. PubMed ID: 3381222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pressor response to vasopressin and impaired baroreflex function in DOC-salt hypertension.
    Matsuguchi H; Schmid PG
    Am J Physiol; 1982 Jan; 242(1):H44-9. PubMed ID: 7058912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of vasopressin to the maintenance of blood pressure in deoxycorticosterone-salt induced malignant hypertension in spontaneously hypertensive rats.
    Hiwatari M; Abrahams JM; Saito T; Johnston CI
    Clin Sci (Lond); 1986 Feb; 70(2):191-8. PubMed ID: 3956109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraventricular nucleus lesions attenuate the development of hypertension in DOCA/salt-treated rats.
    Nakata T; Takeda K; Itho H; Hirata M; Kawasaki S; Hayashi J; Oguro M; Sasaki S; Nakagawa M
    Am J Hypertens; 1989 Aug; 2(8):625-30. PubMed ID: 2570597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pressor responsiveness to vasopressin in the rat with DOC-salt hypertension.
    Crofton JT; Share L; Wang BC; Shade RE
    Hypertension; 1980; 2(4):424-31. PubMed ID: 7399626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex difference in the development of deoxycorticosterone-salt hypertension in the rat.
    Ouchi Y; Share L; Crofton JT; Iitake K; Brooks DP
    Hypertension; 1987 Feb; 9(2):172-7. PubMed ID: 3818014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex difference in pressor responsiveness to vasopressin and baroreflex function in DOC-salt hypertensive rats.
    Ouchi Y; Share L; Crofton JT; Iitake K; Brooks DP
    J Hypertens; 1988 May; 6(5):381-7. PubMed ID: 3385203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemorrhage in DOC-salt hypertensive rats: plasma and platelet vasopressin.
    Crofton JT; Share L; Brooks DP
    Am J Physiol; 1985 Dec; 249(6 Pt 2):R726-31. PubMed ID: 4073293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of vasopressin in the development and maintenance of DOC-salt hypertension in the rat.
    Crofton JT; Share L; Shade RE; Lee-Kwon WJ; Manning M; Sawyer WH
    Hypertension; 1979; 1(1):31-8. PubMed ID: 544512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of endothelin and vasopressin in DOCA-salt hypertension.
    Yu M; Gopalakrishnan V; McNeill JR
    Br J Pharmacol; 2001 Apr; 132(7):1447-54. PubMed ID: 11264238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of AVP in malignant DOC-salt hypertension: studies using vascular and antidiuretic antagonists.
    Filep J; Frölich JC; Földes-Filep E
    Am J Physiol; 1987 Nov; 253(5 Pt 2):F952-8. PubMed ID: 3688242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal function contributes to antihypertensive effect of vasopressin in DOCA-salt but not spontaneous hypertension.
    Wang H; McNeill JR
    Am J Physiol; 1994 Nov; 267(5 Pt 2):H1842-50. PubMed ID: 7977814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal nerves are not necessary for onset or maintenance of DOC-salt hypertension in rats.
    Dzielak DJ; Norman RA
    Am J Physiol; 1985 Nov; 249(5 Pt 2):H945-9. PubMed ID: 4061671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further evidence for abnormal hindquarter tone in spontaneously hypertensive rats.
    Iriuchijima J
    Jpn J Physiol; 1990; 40(4):523-9. PubMed ID: 1981792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of vasopressin, catecholamines, and plasma volume in hypertonic saline-induced hypertension.
    Hatzinikolaou P; Gavras H; Brunner HR; Gavras I
    Am J Physiol; 1981 Jun; 240(6):H827-31. PubMed ID: 7246746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pressor mechanisms of vasopressin in DOC-salt hypertensive rats--interaction with autonomic nervous system.
    Matsuguchi H; Schmid PG
    Jpn Circ J; 1982 May; 46(5):531-3. PubMed ID: 7077815
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of endothelin on resistance arteries of DOCA-salt hypertensive rats.
    Deng LY; Schiffrin EL
    Am J Physiol; 1992 Jun; 262(6 Pt 2):H1782-7. PubMed ID: 1621836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.